Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations
about
sameAs
Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeuticsThalidomide and rituximab in Waldenstrom macroglobulinemiaLong-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab.Novel treatment regimens for Waldenström's macroglobulinemia.Emerging drugs for Waldenström's macroglobulinemia.Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.
P2860
Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expression of serotherapy targ ...... pplications and considerations
@ast
Expression of serotherapy targ ...... pplications and considerations
@en
Expression of serotherapy targ ...... pplications and considerations
@nl
type
label
Expression of serotherapy targ ...... pplications and considerations
@ast
Expression of serotherapy targ ...... pplications and considerations
@en
Expression of serotherapy targ ...... pplications and considerations
@nl
prefLabel
Expression of serotherapy targ ...... pplications and considerations
@ast
Expression of serotherapy targ ...... pplications and considerations
@en
Expression of serotherapy targ ...... pplications and considerations
@nl
P2093
P356
P1433
P1476
Expression of serotherapy targ ...... pplications and considerations
@en
P2093
Abigail Kelliher
Beverly Keele
Christos Emmanouilides
Constantine Mitsiades
Frederic Preffer
Nicholas Mitsiades
Robert Schlossman
Stanley Frankel
Steven P Treon
P304
P356
10.1053/SONC.2003.50047
P407
P577
2003-04-01T00:00:00Z